GATCLIQUID ONCOEXOME by GATC Biotech

Manufacturer GATC Biotech  |  Available Worldwide
Comprehensive profile of all mutations present in the exome


GATCLIQUID ONCOEXOME by GATC Biotech product image
GATCLIQUID ONCOEXOME

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

GATCLIQUID ONCOEXOME is the the first non-invasive service for whole exome sequencing (WES) of circulating tumour DNA (ctDNA). This service allows for a comprehensive profile of all mutations present in the protein coding regions of the genome of suspected cancer patients in cases where limited information on clinically relevant tumour-associated mutations is available.  

Features:

  • Analysis of novel variants, recurrent or frequent somatic mutations in ctDNAome sequencing of cell-free (cfDNA)
  • Coverage of more than 24,000 exons with a sensitivity of 5%
  • Optimised protocols for low-input ctDNA extraction from plasma
  • Proprietary workflows for obtaining libraries of high complexity
  • Expert data processing with QIAGEN Ingenuity Variant Analysis (optional)
  • Carried out under diagnostic standards (ISO17025 accreditation)

 

Product Overview

GATCLIQUID ONCOEXOME by GATC Biotech product image

GATCLIQUID ONCOEXOME

Manufacturer GATC Biotech  |  Available Worldwide

Be the first to review this product